相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Virally vectored vaccine delivery: medical needs, mechanisms, advantages and challenges
Pinschewer D. Daniel
SWISS MEDICAL WEEKLY (2017)
Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine
Yan Zhou et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques
Clarisse Lorin et al.
PLOS ONE (2015)
Vaccines for the 21st century
Isabel Delany et al.
EMBO MOLECULAR MEDICINE (2014)
Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
Daphne A. Stanley et al.
NATURE MEDICINE (2014)
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
Leo Swadling et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses
Shih-Chang Lin et al.
BIOTECHNOLOGY JOURNAL (2013)
Safety and Immunogenicity of DNA Prime and Modified Vaccinia Ankara Virus-HIV Subtype C Vaccine Boost in Healthy Adults
Peter Hayes et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
Anne Fournillier et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
DNA Priming Prior to Inactivated Influenza A(H5N1) Vaccination Expands the Antibody Epitope Repertoire and Increases Affinity Maturation in a Boost-Interval-Dependent Manner in Adults
Surender Khurana et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming Effect
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Robust Immunity to an Auxotrophic Mycobacterium bovis BCG-VLP Prime-Boost HIV Vaccine Candidate in a Nonhuman Primate Model
Gerald K. Chege et al.
JOURNAL OF VIROLOGY (2013)
Prime/Boost Immunization with DNA and Adenoviral Vectors Protects from Hepatitis D Virus (HDV) Infection after Simultaneous Infection with HDV and Woodchuck Hepatitis Virus
Melanie Fiedler et al.
JOURNAL OF VIROLOGY (2013)
Technologies for enhanced efficacy of DNA vaccines
Fadi Saade et al.
EXPERT REVIEW OF VACCINES (2012)
A Triclade DNA Vaccine Designed on the Basis of a Comprehensive Serologic Study Elicits Neutralizing Antibody Responses against All Clades and Subclades of Highly Pathogenic Avian Influenza H5N1 Viruses
Fan Zhou et al.
JOURNAL OF VIROLOGY (2012)
Broader Neutralizing Antibodies against H5N1 Viruses Using Prime-Boost Immunization of Hyperglycosylated Hemagglutinin DNA and Virus-Like Particles
Shih-Chang Lin et al.
PLOS ONE (2012)
SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
Lilin Lai et al.
VACCINE (2012)
SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets
Mario Roederer et al.
CYTOMETRY PART A (2011)
DNA vaccines: an historical perspective and view to the future
Margaret A. Liu
IMMUNOLOGICAL REVIEWS (2011)
HIV-DNA Priming Alters T Cell Responses to HIV-Adenovirus Vaccine Even When Responses to DNA Are Undetectable
Stephen C. De Rosa et al.
JOURNAL OF IMMUNOLOGY (2011)
Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
Paul A. Goepfert et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2011)
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
Julie E. Ledgerwood et al.
LANCET INFECTIOUS DISEASES (2011)
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
Nancy J. Sullivan et al.
NATURE MEDICINE (2011)
Safety and Immunogenicity of an HIV Adenoviral Vector Boost after DNA Plasmid Vaccine Prime by Route of Administration: A Randomized Clinical Trial
Beryl A. Koblin et al.
PLOS ONE (2011)
A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
Gavin J. Churchyard et al.
PLOS ONE (2011)
DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4+ T cells, but few subdominant epitope-specific CD8+ T cells
Lara Vojnov et al.
VACCINE (2011)
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania
Muhammad Bakari et al.
VACCINE (2011)
Robust Vaccine-Elicited Cellular Immune Responses in Breast Milk following Systemic Simian Immunodeficiency Virus DNA Prime and Live Virus Vector Boost Vaccination of Lactating Rhesus Monkeys
Andrew B. Wilks et al.
JOURNAL OF IMMUNOLOGY (2010)
A Phase 1/2 Study of a Multiclade HIV-1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV-Uninfected East Africans (RV 172)
Hannah Kibuuka et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2010)
Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
Richard A. Koup et al.
PLOS ONE (2010)
Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa
Walter Jaoko et al.
PLOS ONE (2010)
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
Lisa E. Hensley et al.
PLOS PATHOGENS (2010)
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
Nancy J. Sullivan et al.
NATURE REVIEWS MICROBIOLOGY (2009)
A prime-boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons
Gerald K. Chege et al.
VACCINE (2009)
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity
Lindvi Gudmundsdotter et al.
VACCINE (2009)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
Patricia A. Darrah et al.
NATURE MEDICINE (2007)
Amine reactive dyes: An effective tool to discriminate live and dead cells in polychromatic flow cytometry
Stephen P. Perfetto et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
DR Casimiro et al.
JOURNAL OF VIROLOGY (2005)
Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers
JM Vuola et al.
JOURNAL OF IMMUNOLOGY (2005)
Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge
NA Doria-Rose et al.
JOURNAL OF VIROLOGY (2003)
Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys
RA Subbramanian et al.
JOURNAL OF VIROLOGY (2003)
Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene
DR Casimiro et al.
JOURNAL OF VIROLOGY (2003)
Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA Vaccines
WP Kong et al.
JOURNAL OF VIROLOGY (2003)
Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine
RR Amara et al.
JOURNAL OF VIROLOGY (2002)
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
RR Amara et al.
SCIENCE (2001)
Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys
DH Barouch et al.
JOURNAL OF VIROLOGY (2001)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
DH Barouch et al.
SCIENCE (2000)
分享论文
